<DOC>
	<DOC>NCT00631033</DOC>
	<brief_summary>The purpose of this study is to determine whether there is an additive effect of metformine on the weight reduction of obese hyperinsulinemic men who are treated with diazoxide.</brief_summary>
	<brief_title>DZX Mediated Insulin Suppression in Obese Men</brief_title>
	<detailed_description />
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Diazoxide</mesh_term>
	<criteria>male age 2550 years BMI 3035 kg/m2 stable body weight during 3 months before the start of the study glucose &lt;= 6.0 mmol/L Cpeptide &gt;= 1.0 nmol/L HbA1c &lt;= 6.0% comorbidity medication serum creatinine &gt; 120 micromol/L liver enzymes &gt; 2 times upper limits of normal gout alcohol use &gt; 2 alcoholic drinks a day drug abuse cessation of smoking less than 6 months ago</criteria>
	<gender>Male</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>obesity</keyword>
	<keyword>hyperinsulinism</keyword>
	<keyword>diazoxide</keyword>
	<keyword>metformin</keyword>
</DOC>